News

Latest News

  • July 11, 2016
    Mazindol granted orphan drug designation in the US & Europe for treatment of Narcolepsy

    READ PRESS RELEASE

  • June 16, 2016
    FDA accepts IND for Phase II Study of Mazindol in Adults with ADHD

    READ PRESS RELEASE

  • May 12, 2016
    NLS Pharma Announces IND submission for Controlled-Release Mazindol to Treat Adults with ADHD.

    READ PRESS RELEASE